In addition, in sample set I the synaptotagmin-1 level was significantly higher in patients with mild cognitive impairment due to Alzheimer’s disease compared with patients with dementia due to Alzheimer’s disease (P ≤ 0.05). The gene discussed is SYT1; the disease is Alzheimer disease.